ARCHIVES

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

April 23, 1982

In Brief: Ethics Commission To Consider Staff Proposal For Compensation Program At Future Meeting

March 13, 1981

Starr Foundation Gives $100 Million To Form Cancer Consortium.

September 29, 2006

NCI Publishes New Atlas Of Cancer Mortality

December 10, 1999

In Brief: Emory Univ. Receives $295 Million Endowment; Winship Cancer Center To Get Half of Income

August 16, 1996

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995